Posts

Genentech expands Oregon manufacturing while Bavarian Nordic delays Lyme vaccine trial

Valneva to cut up to 15% of jobs as reduced travel hits vaccine demand

Pfizer and Valneva's Lyme Vaccine Misses Primary Endpoint But Pursue Regulatory Approval